Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,427 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    New PMPRB Guidelines Will Not Be Implemented January 1, 2023

    The Patented Medicine Prices Review Board (PMPRB) has advised that the new Guidelines will not be implemented on January 1, 2023, and that the Interim Guidance issued by the...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Releases New Draft Guidelines For Comment

    Following its Phase 2 Consultations, on December 19, 2025, the Patented Medicine Prices Review Board (PMPRB) released its new Draft Guidelines and accompanying Overview.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Protecting Health Information: Exploring The Legal Landscape Of Law 5

    On July 1, 2024, the Act respecting health and social services information and amending various legislative provisions (the "Law 5") came into force.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Supreme Court Of Canada Denies Apotex Leave To Appeal Federal Court Of Appeal's Rejection Of Judicial Review Of Health Canada Decision Regarding India Facilities

    As previously reported, the Federal Court of Appeal (FCA) dismissed Apotex's appeal of a judicial review decision of the Therapeutic Products Directorate (TPD) ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Teva And Samsung Bioepis Enter Into Commercialization Agreement For OPUVIZ In Canada

    Teva Pharmaceutical Industries and Samsung Bioepis have announced a strategic partnership to commercialize OPUVIZ, a biosimilar referencing EYLEA, in the Canadian market. The agreement divides responsibilities between Samsung Bioepis handling product registration and manufacturing while Teva Canada leads commercialization efforts. OPUVIZ has already received Health Canada approval for treating multiple eye conditions including wet age-related macular degeneration and diabetic macular edema.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Video

    Remedies In The Federal Court

    In this presentation, Arthur Renaud and Livia Aumand address remedies in the Federal Court.
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    Supreme Court Of Canada Denies Pharmascience Leave To Appeal Decision Upholding The Validity Of Two Patents Relating To ELIQUIS

    On March 30, 2023, the Supreme Court of Canada dismissed Pharmascience's application for leave to appeal (Docket No. 40400) a decision of the Federal Court of Appeal (FCA) upholding the validity...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Being Neighbourly: Canada Welcomes Foreign Defendants In Class Proceedings

    There seems to be a trend developing in United States courts to place limits on class actions, including class proceedings involving pharmaceutical and medical products, but the same cannot be said regarding courts in Canada.
    CanadaLitigation, Mediation & Arbitration
    DLA Piper
    DLA Piper
  • Video

    Pinta Maguire: Why Experience Matters In Medical Malpractice Lawsuits (Video)

    Medical malpractice litigation represents some of the most complex and technical legal work in the country, requiring specialized knowledge, expert witnesses, and a deeply empathetic approach. Senior Counsel Pinta Maguire explains how Gluckstein Lawyers' dedicated team navigates these intricate cases to secure the lifelong care and resources that severely injured individuals desperately need when the public healthcare system falls short.
    CanadaLitigation, Mediation & Arbitration
    Gluckstein Lawyers
    Gluckstein Lawyers
  • Article

    From Lab To App: NiaHealth Raises C$5.75M To Redefine Canadian Health Monitoring

    The Alberta-based startup NiaHealth has secured C$5.75 million in seed funding to support its mission of transforming long-term health management for Canadians.
    CanadaTechnology
    Goodmans LLP
    Goodmans LLP
  • Article

    Ayr Wellness And Liberty Health Sciences Close Plan Of Arrangement

    On February 26, 2021, Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) ("Ayr") and Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty") announced that they had completed...
    CanadaCannabis & Hemp
    Gowling WLG
    Gowling WLG
  • Article

    New Ontario Regulation: Employers Must Comply With The Advice Of The Chief Of Medical Officer Of Health Regarding COVID-19 Vaccination Policies

    On August 24, 2021, the Ontario government filed O. Reg. 577/21, amending O. Reg. 364/20 (Rules for Areas at Step 3 and at the Roadmap Exit Step).
    CanadaCoronavirus (COVID-19)
    WeirFoulds LLP
    WeirFoulds LLP
  • Article

    Connect Hearing Acquires Westside Audiology

    On August 31, 2021, Connect Hearing acquired Westside Audiology, a hearing clinic located in Calgary, Alberta.
    CanadaCorporate/Commercial Law
    Gowling WLG
    Gowling WLG
  • Article

    I Have A Medical Condition And Can't Wear A Mask At Work. Will I Be Fired?

    Labour & Employment partner, Nicole Skuggedal, was featured in The Globe and Mail‘s Nine to Five column.
    CanadaEmployment and HR
    Lawson Lundell LLP
    Lawson Lundell LLP
  • Article

    Considerations In Moving Forward With A Will Challenge

    In some cases, the facts provided by the client strongly suggest that the relative was unlikely to have had the capacity to make the disputed Will.
    CanadaFamily and Matrimonial
    Casey & Moss LLP
    Casey & Moss LLP
  • Article

    Therapy Records Are An Explosive Issue In Custody Battles

    For some years, the courts in Canada have been grappling with the many litigants appearing before them who have mental health issues.
    CanadaFamily and Matrimonial
    Torkin Manes LLP
    Torkin Manes LLP
  • Article

    Aleafia Health Expands Outdoor Cannabis Facility In Port Perry; Sells Unused Property In Brant

    On September 3, 2019, Aleafia Farms Inc., a wholly owned subsidiary of Aleafia Health Inc. (TSX: ALEF) (OTC: ALEAF) (FRA: ARAH),
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Amendments To Food And Drug Regulations (Exports), Natural Health Products Regulations (Labelling)

    The Federal Government has published the following proposed amending regulations in Part 1 of the Canada Gazette...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Bill 168 Requires Hospital Workplace Violence And Harassment Policies

    Bill 168 – An Act to amend the Occupational Health and Safety Act with respect to violence and harassment in the workplace received first reading in the Ontario legislature on April 20, 2009.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Osler, Hoskin & Harcourt LLP
    Osler, Hoskin & Harcourt LLP
  • Article

    BLG Contributes To CBA Submissions On LGBTQ2 Health

    The Federal House of Commons Standing Committee on Health has initiated a study of Lesbian, Gay, Bisexual, Transgender, Queer and Two-Spirit health in Canada.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Showing 101–120 of 3427 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics